Psilocybin: Chemical Foundations and Emerging Therapeutic Potential.

Psilocybin, a naturally occurring psychedelic derived from Psilocybe mushrooms, is experiencing renewed interest for treating mental health disorders, addiction, and cancer-related depression, and its benefits are expanding into brain injury and lifespan due to its ability to enhance neuroplasticity. Its psychoactive effects arise from psilocin acting as a partial agonist at the 5-HT2A receptor. After the FDA's breakthrough therapy designation for treatment-resistant depression in 2018 and major depressive disorder in 2019, large-scale synthesis became a major challenge, requiring complex multi-step processes with strict temperature control and hazardous reagents. Modified versions of Hofmann's original method now enable kilogram-scale production for clinical trials. This mini review covers the history, chemistry, pharmacology, and therapeutic use of psilocybin in depression.

Study at a glance

Abstract

Psilocybin, chemically known as (4-phosphoryloxy-N, N-dimethyltryptamine, 4-PODMT), is derived from the psychoactive mushroom genus, Psilocybe. Of the four active metabolites, psilocin readily enters systemic circulation. The psychoactive effects of psilocin are thought to arise through partial agonist effects at the 5-HT2A receptor. Psychedelic drugs, including psilocybin, are having a renaissance, especially in mental health disorders, addiction, and cancer-related depression. The beneficial effects of psilocybin are expanding into brain injury and lifespan due to its ability to enhance neuroplasticity. However, the large-scale synthesis of psilocybin was the main challenge for the scientific community after the FDA's breakthrough therapy designation in 2018 for Treatment- Resistant Depression (TRD) and for Major Depressive Disorder (MDD) in 2019. Synthesizing psilocybin is challenging due to the complex reactions, a multi-step process that requires strict temperature control, hazardous reagents, and purification difficulties. The very first Hoffman's synthetic method was successfully modified by several medicinal chemistry research groups to obtain it on a kilogram scale to conduct important clinical trials. This mini review comprises a brief history, chemistry, and pharmacology, along with the therapeutic use in depression of this naturally occurring psychedelic.